Abstract. We used the freely available Chemistry Development Kit (CDK) fingerprint to classify 5235 representative molecules taken from ten banned classes in the 2005 World Anti-Doping Agency's (WADA) prohibited list, including molecules taken from the corresponding activity classes in the MDL Drug Data Report (MDDR). We used both Random Forest and k-Nearest Neighbours (kNN) algorithms to generate classifiers. The kNN classifiers with k = 1 gave a very slightly better Matthews Correlation Coefficient than the Random Forest classifiers; the latter, however, predicted fewer false positives. The performance of kNN classifiers tended to decline with increasing k. The performance of the CDK fingerprint is essentially equivalent to that of Unity 2D. Our results suggest that it will be possible to use freely available chemoinformatics tools to aid the fight against drugs in sport, while minimising the risk of wrongfully penalising innocent athletes.
Introduction
Doping comes from the Dutch word "doop", meaning a thick liquid or sauce and originally a South African drink, drunk to help make an individual work harder. Here, we discuss illegal doping in sport, the objective of which is to enhance athletic performance, with little thought as to either the consequences for athletes' health or the integrity of competition. The issue of doping in sport is further complicated by a minefield of legal, political, and ethical questions. The urgency and importance of the battle against drugs in sport was underlined when several of the world's leading cyclists were forcibly withdrawn on the eve of the 2006 Tour de France, following an investigation by Spanish police.
The WADA [1] prohibited list contains 11 different classes of substance: one of these, alcohol (P1), has just one member and is not considered further. Anabolic agents (S1) are artificial synthetic analogues of the male sex hormone testosterone. They are used to promote growth of the skeletal muscles and red blood cells; particularly useful in events such as weightlifting or the 100m sprint, whereby these substances increase muscle size and strength allowing the athlete to train harder. Hormones and related substances (S2) include: erythropoietin, growth hormones, gonadotrophins, insulin and corticotrophins. These substances are taken by athletes to stimulate cell growth and red blood cell production and to increase sugar levels in the blood to avoid fatigue.
The primary medical use of beta-2 agonists (S3) is to treat asthmatic patients during an asthma attack. The drugs are used to open up the airways in the lungs which become restricted following an asthma attack. They are now being used in sport because if injected into the bloodstream they have a powerful anabolic effect that can cause muscle mass to increase and body fat to drop. Anti-estrogenic agents (S4) are substances that prevent the full expression of estrogen. Examples of anti-estrogens include tamoxifen and clomiphene.
Diuretics (S5), normally used to treat heart failure or high blood pressure, have been abused in sport for weight loss and elimination of drugs from the system. Diuretics work by increasing urine production in the kidneys. Sports where diuretics might be abused for promoting weight loss include boxing and lightweight rowing, and indeed any sports where competitors are required to reduce their body weight to below a specified level. Diuretics have been abused as masking agents to dilute the concentration of substances in the urine and avoid detection of other performance-enhancing drugs. Stimulants (S6) increase the activity of the sympathetic nervous system. Examples of stimulants include cocaine, amphetamine and modafinil; caffeine has recently been removed from the WADA prohibited list. These substances make the user feel more alert, energetic and able to concentrate. Narcotics (S7) enhance performance in sport by acting as pain killers. Narcotics allow an injured athlete to continue to train and compete by relieving pain. Examples of narcotics banned in sport include heroin, morphine and fentanyl.
Cannabinoids (S8) have been used to treat pain, migraine, insomnia, nausea and high blood pressure. They are used in sport to relax an athlete before competition. Glucocorticosteroids (S9) are now used as anti-inflammatory agents to treat arthritis and dermatitis. Examples of glucocorticosteroids include hydrocortisone and fludrocortisone acetate. Beta blockers (P2) act as performance-enhancing drugs by lowering the human heart rate and blood pressure, particularly useful in Olympic sports such as archery or shooting where the beta blockers provide more time for the athlete to aim in between heart beats. Examples of beta blockers include acebutolol, alprenolol, nadolol and atenolol.
The repertoire of substances used as doping agents in sport is continually evolving. This leads to an "arms race" between cheats and testers. The former are engaged in the design and synthesis of novel drugs, exemplified by "designer steroids" [2,3] such as tetrahydrogestrinone (THG), which has recently gained notoriety in track and field athletics. The WADA list of prohibited substances uses the phrase "and other substances with a similar chemical structure or similar biological effect(s)" to prohibit analogues of known performance-enhancing molecules. This is a very delicate area legally and ethically, since the authorities run the risk of criminalising athletes who ingest substances which are in some way "similar", without any hard evidence of bioactivity.
Prior to our work, interest in chemoinformatics approaches to drugs in sport appears to have been limited to the single study of Kontaxakis and Christodoulou [4] , devoted to the prediction of chromatographic retention times of prohibited substances using an artificial neural network. Nonetheless, chemoinformatics may have an important role to play, since much of the discipline is built around, firstly, quantifying
